220 related articles for article (PubMed ID: 20170971)
41. A study on the association of cytochrome-P450 1A1 polymorphism and breast cancer risk in north Indian women.
Singh V; Rastogi N; Sinha A; Kumar A; Mathur N; Singh MP
Breast Cancer Res Treat; 2007 Jan; 101(1):73-81. PubMed ID: 16807674
[TBL] [Abstract][Full Text] [Related]
42. Association between normal tissue complications after radiotherapy and polymorphic variations in TGFB1 and XRCC1 genes.
Alsbeih G; Al-Harbi N; Al-Hadyan K; El-Sebaie M; Al-Rajhi N
Radiat Res; 2010 Apr; 173(4):505-11. PubMed ID: 20334523
[TBL] [Abstract][Full Text] [Related]
43. Association between polymorphisms of the ataxia telangiectasia mutated gene and breast cancer risk: evidence from the current studies.
Lu PH; Wei MX; Si SP; Liu X; Shen W; Tao GQ; Chen MB
Breast Cancer Res Treat; 2011 Feb; 126(1):141-8. PubMed ID: 20665102
[TBL] [Abstract][Full Text] [Related]
44. ATM haplotypes and cellular response to DNA damage: association with breast cancer risk and clinical radiosensitivity.
Angèle S; Romestaing P; Moullan N; Vuillaume M; Chapot B; Friesen M; Jongmans W; Cox DG; Pisani P; Gérard JP; Hall J
Cancer Res; 2003 Dec; 63(24):8717-25. PubMed ID: 14695186
[TBL] [Abstract][Full Text] [Related]
45. Polymorphisms in the DNA repair gene XRCC1, breast cancer risk, and response to radiotherapy.
Moullan N; Cox DG; Angèle S; Romestaing P; Gérard JP; Hall J
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1168-74. PubMed ID: 14652276
[TBL] [Abstract][Full Text] [Related]
46. Functional consequences of ATM sequence variants for chromosomal radiosensitivity.
Gutiérrez-Enríquez S; Fernet M; Dörk T; Bremer M; Lauge A; Stoppa-Lyonnet D; Moullan N; Angèle S; Hall J
Genes Chromosomes Cancer; 2004 Jun; 40(2):109-19. PubMed ID: 15101044
[TBL] [Abstract][Full Text] [Related]
47. Polymorphisms in the DNA repair gene XRCC1 and breast cancer.
Duell EJ; Millikan RC; Pittman GS; Winkel S; Lunn RM; Tse CK; Eaton A; Mohrenweiser HW; Newman B; Bell DA
Cancer Epidemiol Biomarkers Prev; 2001 Mar; 10(3):217-22. PubMed ID: 11303590
[TBL] [Abstract][Full Text] [Related]
48. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
[TBL] [Abstract][Full Text] [Related]
49. X-ray repair cross-complementing group 4 (XRCC4) promoter -1394( *)T-related genotype, but not XRCC4 codon 247/intron 3 or xeroderma pigmentosum group D codon 312, 751/promoter -114, polymorphisms are correlated with higher susceptibility to myoma.
Hsieh YY; Chang CC; Bau DT; Yeh LS; Tsai FJ; Tsai CH
Fertil Steril; 2008 Oct; 90(4 Suppl):1417-23. PubMed ID: 18177646
[TBL] [Abstract][Full Text] [Related]
50. Polymorphisms in DNA repair gene XRCC1 and increased genetic susceptibility to breast cancer.
Chacko P; Rajan B; Joseph T; Mathew BS; Pillai MR
Breast Cancer Res Treat; 2005 Jan; 89(1):15-21. PubMed ID: 15666192
[TBL] [Abstract][Full Text] [Related]
51. Polymorphisms of the DNA repair genes XRCC1, XRCC3, XPD, interaction with environmental exposures, and bladder cancer risk in a case-control study in northern Italy.
Shen M; Hung RJ; Brennan P; Malaveille C; Donato F; Placidi D; Carta A; Hautefeuille A; Boffetta P; Porru S
Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1234-40. PubMed ID: 14652287
[TBL] [Abstract][Full Text] [Related]
52. Associations between XPD polymorphisms and risk of breast cancer: a meta-analysis.
Jiang Z; Li C; Xu Y; Cai S; Wang X
Breast Cancer Res Treat; 2010 Aug; 123(1):203-12. PubMed ID: 20111903
[TBL] [Abstract][Full Text] [Related]
53. [Polymorphism Lys751Gln of XPD gene and breast cancer risk in women].
Romanowicz-Makowska H; Smolarz B
Pol Merkur Lekarski; 2007 Aug; 23(134):107-9. PubMed ID: 18044339
[TBL] [Abstract][Full Text] [Related]
54. The XPD 751Gln allele is associated with an increased risk for esophageal adenocarcinoma: a population-based case-control study in Sweden.
Ye W; Kumar R; Bacova G; Lagergren J; Hemminki K; Nyrén O
Carcinogenesis; 2006 Sep; 27(9):1835-41. PubMed ID: 16571649
[TBL] [Abstract][Full Text] [Related]
55. Association of P53 and ATM polymorphisms with risk of radiation-induced pneumonitis in lung cancer patients treated with radiotherapy.
Yang M; Zhang L; Bi N; Ji W; Tan W; Zhao L; Yu D; Wu C; Wang L; Lin D
Int J Radiat Oncol Biol Phys; 2011 Apr; 79(5):1402-7. PubMed ID: 20729006
[TBL] [Abstract][Full Text] [Related]
56. Polymorphic Variants in Oxidative Stress Genes and Acute Toxicity in Breast Cancer Patients Receiving Radiotherapy.
Córdoba EE; Abba MC; Lacunza E; Fernánde E; Güerci AM
Cancer Res Treat; 2016 Jul; 48(3):948-54. PubMed ID: 26790968
[TBL] [Abstract][Full Text] [Related]
57. Association of XPD polymorphisms with prostate cancer in Taiwanese patients.
Bau DT; Wu HC; Chiu CF; Lin CC; Hsu CM; Wang CL; Wang RF; Tsai FJ
Anticancer Res; 2007; 27(4C):2893-6. PubMed ID: 17695467
[TBL] [Abstract][Full Text] [Related]
58. No effect of the transforming growth factor β1 promoter polymorphism C-509T on TGFB1 gene expression, protein secretion, or cellular radiosensitivity.
Reuther S; Metzke E; Bonin M; Petersen C; Dikomey E; Raabe A
Int J Radiat Oncol Biol Phys; 2013 Feb; 85(2):460-5. PubMed ID: 22592044
[TBL] [Abstract][Full Text] [Related]
59. [Adjuvant irradiation in breast cancer patients with ATM gene heterozygous mutations: special focus on clinical efficacy/toxicity].
Chargari C; Kirova YM; Even C; Monnier L; Dendale R; Campana F; Fourquet A
Cancer Radiother; 2009 Jun; 13(3):164-72. PubMed ID: 19162519
[TBL] [Abstract][Full Text] [Related]
60. Breast cancer in female carriers of ATM gene alterations: outcome of adjuvant radiotherapy.
Meyer A; John E; Dörk T; Sohn C; Karstens JH; Bremer M
Radiother Oncol; 2004 Sep; 72(3):319-23. PubMed ID: 15450731
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
